Monthly Archives: May 2013

FDA “It Has Come to Our Attention” Letter on Medical App

Posted on May 29, 2013 by Mark Senak

There are Warning Letters, Untitled Letters, otherwise known as Notice of Violation Letters, and now there is the “It Has Come to Our Attention Letter”.  I have to admit, I had not heard of this particular kind of letter before, … Continue reading →

Posted in Medical Apps | Comments Off on FDA “It Has Come to Our Attention” Letter on Medical App

Weekly Roundup 5-24-13

Posted on May 24, 2013 by Mark Senak

Yee Hah!  Memorial Day weekend is upon us – and not a moment too soon.  It is time for hectic Spring to ease into lazier days of Summer.  I hope.  As for me, it may seem that I have been … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup 5-24-13

Weekly Roundup 5-17-13

Posted on May 17, 2013 by Mark Senak

It has been a busy May.  From working in the yard to transform it from looking like property on which Boo Radley might have a house to putting on panel discussions and layers of business travel to grading papers and … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup 5-17-13

Webinar on FDA Communications Oversight in a Digital Era

Posted on May 13, 2013 by Mark Senak

Many may recall that in early April, I released a paper I did here on Eye on FDA called “FDA Communications Oversight in a Digital Era” that examined the patterns of enforcement by FDA’s Office of Prescription Drug Promotion as … Continue reading →

Posted in Warning Letters | Comments Off on Webinar on FDA Communications Oversight in a Digital Era

Weekly Roundup 5-3-13

Posted on May 3, 2013 by Mark Senak

The grass is not greener on my side, mainly because it is mostly not there.  The lawn, if you want to call it that, looks like it needs a lot of attention – probably more than I have to give … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup 5-3-13